The idiotype defined by the levan-specific BALB/c myeloma protein ABPC48 (A48) has previously been encountered only in antibodies the variable regions of which derive from the VHX24 and VK1O gene families. We have demonstrated expression of the idiotope recognized by the monoclonal anti-A48 idiotype antibody IDA10 on five monoclonal antibodies from different mouse strains, with different specificities including foreign and self antigens and deriving their variable regions from families other than VHX24 and VJ1O. We analyzed variable region protein structure (deduced from nucleotide sequences) and hydrophilicity profiles of idiotype' and idiotypeantibodies. We identified four surfaceexposed areas (one in the heavy chain and three in the light chain) that may contribute to expression of the idiotope defined by antibody lDA10.
BALB/c mice immunized with bacterial levan produce antibodies against both 82-6 and 82-1 linkages of this polyfructosan (1) . A small fraction (<10o) of these antibodies express the idiotype found on the BALB/c anti-levan myeloma protein, ABPC48 (A48). However, if these mice are immunized with syngeneic polyclonal anti-A48 idiotype antibodies and challenged with levan, they produce A48 idiotype-bearing immunoglobulin (2) . Some of these immunoglobulins exhibit levan-binding activity but the vast majority do not (3) . It was speculated that the latter component represents clones activated through a cross-regulation mediated by anti-idiotype B or T cells (4) . Such clones might have reactivity to self determinants or other unrelated nonselfepitopes. In this study we screened for A48 idiotype expression 68 monoclonal antibodies (mAbs) originating from various mouse strains and having distinct antigen specificities (Table 1) .
Among this panel, five antibodies were found to bind to the anti-A48 idiotype mAb IDA10. Because A48 idiotype expression was shown to be restricted to the VHX24 and VK10 gene families (12, 13) , we studied the variable-region genes encoding these antibodies. Surprisingly, we found that their heavy and light chains derived from various gene families. Nucleotide sequence analysis of heavyand light-chain variable regions of these idiotype positive (Id') antibodies has identified amino acid residues that may contribute to the expression of the A48 idiotype.
MATERIALS AND METHODS
The syngeneic (BALB/c) anti-A48 idiotype mAb IDA10 (14) was provided by Pierre Legrain (Pasteur Institute, Paris). The mAb 3.14.9, prepared in our laboratory, has been described (12) . Radioimmunoassays . Idiotype expression was assessed by using a sandwich binding assay performed as follows: microtiter plates were coated overnight at 4TC with antibodies at 2 ,ug/ml, washed, and saturated with 1% bovine serum albumin in phosphate-buffered saline. After washing, 90 ng of mAb IDA10 per well was added, and the plates were incubated overnight at room temperature. Bound mAb IDA10 was revealed after 3-hr incubation at 370C with 50,000 cpm of '251-labeled A48 idiotype.
For the inhibition assay, microtiter plates were coated overnight at 4TC with 100 Aul of mAb IDA10 (2 Ag/ml), washed, and saturated with 1% bovine serum albumin in phosphate-buffered saline. The competition for binding to mAb IDA10 was performed by adding serial dilutions of antibodies together with 20,000 cpm of 125I-labeled mAb 3.14.9. After 18-hr incubation at 37°C, the plates were washed and counted.
Western (Immunologic) Blot Analysis. The antibodies (1 ,g) were reduced with mercaptoethanol (25 x 10-2 M), and heavy and light chains were separated by SDS/PAGE (10% acrylamide). Proteins were then transferred to DEAEmembrane by the Bio-Rad Transblot system. After overnight saturation with 2% (wt/vol) casein in 0.2 M sodium carbonate buffer, the membrane was incubated for 2 hr at room temperature in a solution containing 1251I-labeled mAb IDA10 or rabbit anti-mouse immunoglobulin antibodies (106 cpm/ ml; 10 ml). The membrane was then extensively washed with 50 mM Tris HCl, pH 8.2, containing 0.05% Tween 20 and autoradiographed.
Molecular Techniques, Variable Region Gene Probes. The source and the size of the VH81X (VH7183 family), the VHNP.B4 (VHJ558 family), the VK8, the VK4, the VK21, and the VK10 probes used in this study have been described in detail elsewhere (11) . The bacterial transfection with plasmids, plasmid purification, probe preparation, and [a-32P]dCTP nick-translation were also performed as described (11) .
Northern (RNA) Blot Analysis. Total RNA was extracted using the guanidinium thiocyanate procedure (15) . Northern blot analysis was performed as described (11) .
Cloning. Poly(A)+ mRNA was isolated after one cycle of selection over a type 3 oligo(dT)-cellulose column according to the method described by Aviv and Leder (16) . Doublestranded cDNA synthesis was accomplished using a kit manufactured by Amersham in conjunction with previously described immunoglobulin C region-specific oligonucleotide primers (17) commercially prepared by OCS Laboratories (Denton, TX). The double-stranded cDNA was 3' tailed with dCTP and hybridized with a 3' dG-tailed pUC-9 plasmid Abbreviations: CDR, complementarity-determining region; IDR, idiotope-defining region; mAb, monoclonal antibody; VH, heavychain variable region; VK, K chain variable region; Id', idiotype positive; Id-, idiotype negative.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. DBA/1 E7(CII) The antigen specificity and VH typing of these antibodies are published elsewhere (5) (6) (7) (8) (9) (10) (11) . For idiotypic studies these antibodies were affinity-purified from culture medium on a mAb rat anti-mouse K chain coupled to Sepharose 4B. ds DNA, double-stranded DNA; RF, rheumatoid factor; SA, skin antigen; H1, hemagglutinin of PR8 influenza virus; H3, hemagglutinin of X31 influenza virus; TG, thyroglobulin; Sm, Smith antigen; MBP, myelin basic protein; IF, intrinsic factor; Thy, thymocytes; Br-RBC, bromelain-treated erythrocytes; CII, collagen type II; al-3Dex, al-3 linked glucose polymer; NP, (4-hydroxy-3-nitrophenyl)acetyl; PCho, phosphorylcholine; NA, nuclear antigen; inu, inulin; TNP, trinitrophenyl. *Myeloma proteins were purified from ascites by chromatography over protein A or the appropriate antigen coupled to Sepharose 4B.
(Pharmacia) and transfected into JM101 bacteria by published methods (18) .
Sequencing. Two micrograms of supercoiled plasmid DNA were denatured in 0.2 M sodium hydroxide and hybridized to 20 ng of either JP-pUC19 (HindIII) primer (CAGGAAACA-GCTATG) or JP-pUC19 (EcoRI) primer (AAACGACGGC-CAGTG) (prepared and provided by M. Krystal, Mount Sinai School of Medicine, New York). The sequencing reaction was performed using the Sequenase kit manufactured by United States Biochemical.
RESULTS
A48 Idiotype Expression on mAbs Having Antigen Specificities Other Than Levan. Among 68 mAbs originating from different mouse strains and exhibiting various antigenbinding specificities, five mAbs were found to express the A48 idiotype as defined by the syngeneic anti-idiotype mAb IDA10. The data depicted in Table 2 show that microtiter wells coated and then incubated with mAb IDA10 bind the Id+ 1251I-labeled A48 protein. The binding to Z26 and M56 was 2to 3-fold lower than two prototype A48 Id' antibodies (A48 and 3.14.9) and was similar to the binding of mAb IDA10 to another A48 Id+ levan-binding BALB/c myeloma protein, UPC10 (12) . Three other mAbs-XY101, PY102, and Y19-10-showed weaker binding compared with mAbs Z26 and M56 but 2to 3-fold higher than the binding of IDA10 to mAb J606, which lacks the A48 idiotype. Expression of the A48 idiotype on these antibodies was supported by a competitive inhibition assay in which these antibodies inhibited the binding of radiolabeled mAb 3.14.9 to IDA10. As shown in Table 2 , mAbs Z26 and M56 strongly inhibited the binding of mAb 3.14.9 to IDA10, whereas mAbs PY102, XY101, and Y19-10 displayed a weaker inhibitory capacity, though still significantly higher compared with mAbs J606 and bovine serum albumin. From these results, we concluded that mAbs Z26 and M56 exhibiting anti-Smith antigen specificity, the rheumatoid factor Y19-10, and PY102 and XY101 specific for the hemagglutinin of influenza viruses expressed an A48 idiotope.
Conformational Nature of the A48 Idiotype. Because the A48 idiotype was found on antibodies having distinct antigen activities encoded by variable regions from different variableregion gene families (Table 2) we studied the contribution of heavy and light chains to such idiotype expression. The Western blotting analysis depicted in Fig. 1 shows that IDA10 binds to intact molecules but not to reduced and separated heavy and light chains. The staining of a duplicate gel with 1251I-labeled rabbit anti-mouse immunoglobulin antibody instead of IDA10 showed binding to intact antibody molecules as well as to separated heavy and light chains (data not shown). Thus, it appears that A48 idiotype expression requires the contribution of both chains, suggesting its conformational nature.
Antibodies Expressing the A48 Idiotype Are Encoded by Genes from Various Families. Northern (RNA) blotting analysis showed that mAb 3.14.9 uses VHX24, whereas mAbs Z26, PY102, and XY101 use heavy-chain variable region genes derived from the VH7183 family, mAbs M56 and Y19-10 use VH genes from the VHJ558 family. mAb 3.14.9 uses VK1O; mAbs M56, Z26, and PY102 use genes derived from the VK8 family, mAb XY101 uses genes from VK21, and FIG.I1. Analysis of the contributions of antibody heavy and light chains to A48 idiotype expression was performed by Western blotting of unreduced or reduced antibodies detected with radiolabeled IDA10. Antibodies labeled with stars were not reduced, those labeled with circles were reduced before electrophoresis. The A48 Id' mAbs 3.101.14, 3.9.9, and 3.27.6 (and the myeloma protein J606) are IgG. mAbs Z26, M56, and 3.14.9 (IgM) and A48 (IgA) do not enter the gel in the unreduced state. mAb Y19-10 uses genes derived from VK4 (Northern blots are not shown; the data are summarized in Table 2 ). Comparison of variable-region gene nucleotide sequences ofmAbs 3.14.9, Z26, PY102, M56, and Y19-10 to representative germ-line genes confirmed the assignments to gene families made by Northern blotting (data not shown).
A48 Id' antibodies (including 3.14.9) have previously been shown to derive their VH regions from a gene of the VHX24 gene family (12, 13) . This family contains two genes having 98% identity in the coding regions (23) . VH nucleotide sequences of mAbs Z26, PY102, Y19-10, and M56 were compared with one of the germ-line genes of the VHX24 family (Fig. 2 ). The mAb Z26 VH sequence has highest identity with VH441 (75%), whereas mAb Y19-10 has the lowest identity (57%). At the amino acid level, mAb PY102 has highest identity (66%), whereas mAbs Y19-10 and M56 both have 45% identity (data not shown). These VH regions use diversity-region genes from the DSP2 and DFL16 gene families and heavy-chain joining genes 1, 3, and 4. In Fig. 3 we compare the VK nucleotide sequences of mAbs 3.14.9, PY102, Z26, and M56 with the sequence of an A/J strain germ-line VK10 gene. Not surprisingly, the 3-14-9 VK1O gene has highest identity (99%, 98% at the amino acid level). Of the other genes, M56 has the highest (63%), whereas PY102 has lowest (59%) identity. The amino acid identities of these VK regions are 55% and 49o, respectively. All four antibodies use different JK segments; 3.14.9 uses JK1, PY102 uses JK5, Z26 uses JK2, and M56 uses J4. Correlation of A48 Idiotype Expression to Structural Features of Both VH and the Variable Region of the K Chain (VK).
In an attempt to correlate idiotype expression to variableregion protein structure, we performed the predicted hydrophilicity profiles (26) of the deduced amino acid sequences of the heavy and light chains of these A48 Id' and other A48 idiotype minus (Id-) mAbs from those listed in Table 1 . Such a profile predicts the surface-exposed amino acids that might constitute antigenic determinants. Among the heavy chains of A48 Id' mAbs, we found only one shared predicted surface-exposed region containing the aspartic acid in position 72 (Kabat numbering, ref. 28 ) that is conserved in most murine VH domains (Fig. 4) . This region is also hydrophilic in A48 Id-mAbs. However, all six A48 Id' sequences have either Asn-Ala or Lys-Ser at positions 73,74, whereas only 2 of 11 Idsequences have one of these combinations.
Using a similar analysis for the light chains, we found three common groups of surface-exposed amino acids in A48 Id' mAbs centered around the conserved Ser-26, the conserved Lys-39 and Pro-40, and the conserved Glu-81 and Asp-82 ( Fig. 4) . These regions are also hydrophilic in Id-mAbs. DISCUSSION Study of the variable region genes in hybridomas producing antibodies binding polyfructosans and expressing A48 regulatory idiotopes showed that they derive from the VHX24 and VK10 families (12, 13) . Western blotting analysis of the binding of the anti-A48 idiotype mAb IDA10 to A48 Id' antibodies clearly demonstrated that the idiotope defined by this anti-idiotype is a conformational determinant requiring both heavy and light chains. We present data showing that 5 10 15 20 25
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FIG. 2. Comparison ofVH nucleotide sequences ofthe A48 Id' mAbs Z26, PY102, Y19-10, and M56 to the VH441 germ-line gene (23) . Dashes indicate nucleotide identity. The diversity-region segment gene families (24) and joining-region genes used are indicated. GAC ATT AGC AAT TAT TTA AAC TGG  TA- 
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TAT CAG CAG AAA CCA GAT 20 25 27a ACC ATC AGT TGC AGG GCA AGT CAG
GGA ACT GTT AAA CTC CTG ATC TAC TAC FIG. 3 . Comparison of the VK nucleotide sequences of mAbs 3.14.9, PY102, Z26, and M56 to an A/J strain VK1O germ-line gene, VK-GL (25) . this conformational idiotypic determinant can be created by pairing of variable region genes deriving from other variable region gene families and can be expressed by antibodies exhibiting various antigen specificities.
The groups ofpredicted surface-exposed residues common to the A48 Id' sequences correspond to some of the IDRs described in the immunoglobulin surface variability analysis of Kieber-Emmons and Kohler (27) . The group of homologous residues in the heavy chain corresponds to IDR D, whereas those in the light chain correspond to IDRs A, C, and part of E (Fig. 4) . No heavy or light chains had surfaceexposed and IDR-located areas not shared by all A48 Id' mAbs we sequenced. A few surface-exposed areas outside the IDRs were unique to one sequence or shared by a few. However, these regions did not appear to correlate with idiotype expression. Of the combinations of residues we have associated with heavy chains of Id' sequences, Asn-Ala is found in positions (26) greater than or equal to 0; lowercase letters denote residues with hydrophilicity <0. The idiotope-defining regions (IDRs) (27) are indicated. An asterisk indicates residues conserved in the majority of murine immunoglobulins. A plus indicates residues that may contribute to the conformational structure required for expression of the A48 idiotope defined by IDA10. All sequences of A48 Id-antibodies are from Kabat et al. (28) except for mAbs CP5 (29) and 129-48 (9). 73 and 74 in 18/23 (78%) of VHX24, whereas Lys-Ser is found in 91/141 (65%) of VHJ558 sequences. Either combination is found in 15/143 (10%) of sequences from other VH gene families (28) . The overall high frequency of occurrence of these combinations (124/307 or 40%o) would again suggest that pairing with an appropriate light chain must play an important role in idiotype expression because of the 68 mAbs tested, only five (7%) were found to be Id'.
In the light chains, the residues associated with Id' antibodies in each of the three surface-exposed areas also correlate with variable region gene families in a similar way. However, the concurrence of these combinations of residues in a single light chain is relatively rare. In a survey of K light-chain sequences (28), 18/227 (8%) were found to have all three combinations of residues associated with idiotype expression.
We assume neither that these residues are all of those that may contact the anti-idiotype nor that they are themselves all contacting residues. These amino acids could determine idiotope structure by influencing the spatial location of residues that may also occur in Id-mAbs in positions inappropriate for Id-anti-idiotype interaction. Furthermore, influences of other structures not evident to this analysis may render variable regions possessing all four combinations of residues Id-. We feel that this type of analysis generates several specific predictions that serve to focus subsequent probes of variable region structure, such as utilization of synthetic peptides or molecular methods such as site-directed mutagenesis.
The significance of these findings is 2-fold. (i) Our data clearly demonstrate that cross-reactive idiotypes are not solely markers of genes derived from a single variable region gene family. We have shown that a conformational idiotypic determinant of A48, previously thought restricted to variable regions derived from VHX24 and VK10, can be expressed on antibodies deriving their variable regions from various families. The ability to form similar variable region structures using variable region genes from different families extends to the combining site, as well. Akolkar et al. (30) have recently shown that several antibodies specific for a(1-6) dextran derive their variable regions from various gene families.
(ii) These data shed light on the molecular basis of idiotype-determined cross-regulatory processes connecting clones specific for foreign or self antigens. The potential exists for Id' clones to be activated or suppressed by anti-idiotype antibodies or T cells. This possibility should be considered when devising strategies for the use of idiotype or anti-idiotype antibodies as therapeutic agents or vaccines. This study was supported by Grant IM275 from the American Cancer Society, and National Science Foundation Grant DCB-8709 711. H.Z. was supported by a grant from the Association de la Recherche sur le Cancer (Villejuif, France). F.A.B. was supported by a Medical Scientist Training Grant GMO-7280 from the National Institute of General and Medical Sciences.
